Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Group 2 innate lymphoid cells (ILC2s) are recently discovered lymphocytes that have innate ability to produce a specific set of hormone-like proteins called cytokines. While the importance of ILC2s in allergic diseases including asthma have been implicated by recent reports, the progress in our understanding of ILC2s has been hampered by the fact that they are rather rare lymphocytes and difficult to detect or isolate. The goal of our project is to develop rapid and simple method to isolate ILC2s from mice and humans. We plan to combine our knowledge and experience in mouse ILC2s with the cell separation technologies of the partner organization STEMCELL Technologies Inc. to develop ILC2 isolation kits. The kits to be developed will become invaluable tools for interns’ own researches. The kits will also become new products for STEMCELL. They will likely become popular and profitable products.
Fumio Takei
STEMCELL Technologies Canada Inc
Life Sciences
Health and Related Sciences & Technology; Biotechnology; Life Sciences (not health)
The University of British Columbia
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.